Coloplast presents revised 2030 ambition for 5-7% annual organic growth
Coloplast revised its 2030 ambition to 5-7% annual organic growth and a mid-20% EBIT margin in constant currencies, before special items. FY 2025/26 revenue rose 4% to DKK 28.94 billion, while EBIT before special items fell 3% to DKK 7.45 billion.
1. Revised targets and results
Coloplast revised its 2030 ambitions to 5-7% annual organic growth and a mid-20% EBIT margin in constant currencies, before special items. The company cited higher growth investments and external headwinds, and said a cost-saving program targets DKK 500 million, fully effective in FY 2027/28. For FY 2026/27, it expects 5-7% organic growth and an EBIT margin around 25% in constant currencies, before special items. FY 2025/26 revenue rose 4% to DKK 28.94 billion, with 6% organic growth; EBIT before special items fell 3% to DKK 7.45 billion, and the reported margin narrowed to 26% from 28%.
